Compare Definium Therapeutics Inc. Common Shares (DFTX) vs LifeStance Health Group Inc. Common Stock (LFST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs LifeStance Health Group Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while LifeStance Health Group Inc. Common Stock trades at $12.07 (market cap $4.62B). The key difference: Definium Therapeutics Inc. Common Shares and LifeStance Health Group Inc. Common Stock are close in size by market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and LifeStance Health Group Inc. Common Stock for 0 Days on average.
| DFTX | LFST | |
|---|---|---|
Market Cap | $4.71B | $4.62B |
Volume | 1,966,636 | 3,652,940 |
Sector | Health | Health |
52-Week High | $48.45 | $13.38 |
52-Week Low | $10.68 | $4.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $4.85B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About LifeStance Health Group Inc. Common Stock
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →
